How our research benefits to society
Much of our research has implication for personalised prevention and medicine.
- The focus will be on building prediction models, including genetic risk scores and gene–environment interaction models for (early) development of type 2 diabetes, chronic kidney disease, glaucoma, obesity, and hypertension. These studies increasingly involve epigenetics as a molecular interface between genes and the environment.
- We are exploring machine learning algorithms to facilitate precision medicine in the intensive care.
- We lead the UMCG Genetics Lifelines Initiative (UGLI), with the goal to perform genome-wide genotyping for the entire Lifelines study.